Serum interα-trypsin inhibitor heavy chain H4 may be an anti-inflammatory marker reflecting disease risk, activity and treatment outcome of ankylosing spondylitis

Scandinavian Journal of Clinical and Laboratory Investigation Pub Date : 2023-12-29 DOI:10.1080/00365513.2023.2250986

Zhumin Sun, Yang Zhang, Haiyan Zhou, Jingyun Li, Yue Zhou, Liyun Wang

引用次数: 0

Abstract

Interα-trypsin inhibitor heavy chain H4 (ITIH4) modulates inflammation and immunity, which take part in the pathogenesis of ankylosing spondylitis (AS). The current research intended to discover th...

查看原文本刊更多论文

血清α-胰蛋白酶抑制剂重链 H4 可能是反映强直性脊柱炎疾病风险、活动性和治疗效果的抗炎标志物

α-胰蛋白酶间抑制物重链H4（ITIH4）能调节炎症和免疫，而炎症和免疫参与了强直性脊柱炎（AS）的发病机制。目前的研究旨在发现...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Scandinavian Journal of Clinical and Laboratory Investigation

自引率

0.00%

发文量